4//SEC Filing
LEVANGIE DANIEL J 4
Accession 0001209191-19-044253
CIK 0001124140other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 4:24 PM ET
Size
29.0 KB
Accession
0001209191-19-044253
Insider Transaction Report
Form 4
LEVANGIE DANIEL J
Director
Transactions
- Sale
Common Stock
2019-07-31$114.83/sh−2,828$324,739→ 52,237 total - Sale
Common Stock
2019-07-31$115.65/sh−9,284$1,073,695→ 42,953 total - Exercise/Conversion
Stock Option (right to buy)
2019-07-31−7,667→ 0 totalExercise: $3.43From: 2011-07-16Exp: 2020-07-16→ Common Stock (7,667 underlying) - Exercise/Conversion
Common Stock
2019-07-31$3.43/sh+19,168$65,746→ 31,626 total - Sale
Common Stock
2019-07-31$117.72/sh−9,572$1,126,816→ 31,081 total - Exercise/Conversion
Stock Option (right to buy)
2019-07-31−15,772→ 0 totalExercise: $8.52From: 2012-07-28Exp: 2021-07-28→ Common Stock (15,772 underlying) - Exercise/Conversion
Common Stock
2019-07-31$3.43/sh+7,667$26,298→ 39,293 total - Sale
Common Stock
2019-07-31$120.24/sh−100$12,024→ 12,458 total - Exercise/Conversion
Stock Option (right to buy)
2019-07-31−19,168→ 0 totalExercise: $3.43From: 2011-07-16Exp: 2020-07-16→ Common Stock (19,168 underlying) - Exercise/Conversion
Common Stock
2019-07-31$8.52/sh+15,772$134,377→ 55,065 total - Sale
Common Stock
2019-07-31$116.47/sh−2,300$267,881→ 40,653 total - Sale
Common Stock
2019-07-31$118.73/sh−9,626$1,142,895→ 21,455 total - Sale
Common Stock
2019-07-31$119.63/sh−8,897$1,064,348→ 12,558 total
Footnotes (8)
- [F1]Represents shares of common stock received upon exercise of a stock option award.
- [F2]The sales reported in this Column 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 25, 2019, a portion of which were sold to cover certain tax liabilities arising out of the vesting of shares of restricted stock.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.09 to $115.08, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.115 to $116.10, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.13 to $116.96, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.18 to $118.18, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.20 to $119.18, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.23 to $120.23, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
Documents
Issuer
EXACT SCIENCES CORP
CIK 0001124140
Entity typeother
Related Parties
1- filerCIK 0001187406
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 4:24 PM ET
- Size
- 29.0 KB